Overview
Jardiance Met Tablets combine two active ingredients, Empagliflozin (12.5 mg) and Metformin (500 mg), used for the treatment of type 2 diabetes mellitus. This combination helps control blood sugar by reducing glucose absorption in the kidneys (Empagliflozin) and decreasing glucose production in the liver while improving insulin sensitivity (Metformin). It aids in achieving better glycemic control and can also support weight management.





